Monocanalicular Intubation Assembly with Reversible Mandrel Extraction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing monocanalicular intubation assemblies require general anesthesia and risky nasal manipulation to extract the mandrel, complicating the unclogging of blocked tear ducts, especially in infants.

Innovation Solution

A monocanalicular and/or monocanaliculonasal intubation assembly with a shorter silicone tube and a mandrel that is partially inserted into the tube, allowing extraction from the eye side, eliminating the need for nasal intervention and reducing the risk of reactive hyperplasia through a designed stopper and slit configuration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If the mandrel is extracted from the nasal side, then the tear duct can be unclogged, but the procedure requires general anesthesia and carries significant risks

Engineering Contradiction:
Improvesafety of procedureVSAvoidcomplexity of extraction procedure
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The mandrel is extracted from the ocular side (opposite to the conventional nasal side extraction). The assembly is introduced from the eye side, and the mandrel is pulled out through the same eye side, completely avoiding nasal manipulation and the associated risks of general anesthesia

Inventive Principle:
Principle #13The other way round (Inversion)

2Length of moving object

If a long silicone tube is used to reach the nasal end, then the tear duct can be traversed, but the manufacturing cost increases

Engineering Contradiction:
Improvelength of silicone tubeVSAvoidmanufacturing cost
Core Design Contradiction:
Length of moving objectVSEase of manufacture

Solution Approach 1:

The mandrel is extracted from the ocular side rather than being pulled through to the nasal side. This eliminates the need for a long silicone tube extending to the nasal end, as the mandrel removal path is reversed, thereby reducing material usage and manufacturing cost

Inventive Principle:
Principle #2Taking out (Extraction)

3Ease of operation

If the tube opens at the proximal end, then the mandrel can pass through, but the canalicular epithelium undergoes reactive hyperplasia

Engineering Contradiction:
Improvemandrel passageVSAvoidreactivehyperplasia
Core Design Contradiction:
Ease of operationVSObject-generated harmful factors

Solution Approach 1:

A slit opening is created in the tube wall instead of a proximal end opening. This localized modification allows mandrel passage while preventing the canalicular epithelium from colonizing the opening, thus avoiding reactive hyperplasia. The slit is positioned and dimensioned to permit mandrel insertion while blocking epithelial ingrowth

Inventive Principle:
Principle #3Local quality

Data Source

PatentEP2086479B1Monocanaliculonasal and/or monocanalicular intubation assembly for nasolacrimal imperforation
Publication Date: 2012.10.03 FCI (FRANCE CHIRURGIE INSTRUMENTATION) SA
  • EP2086479B1 patent drawingFigure 1~4

AI summary

The invention relates to a monocanaliculonasal and/or monocanalicular intubation assembly mainly intended for nasolacrimal imperforation, comprising a mandrel (2) made of a first essentially rigid material such as a metal, and a tube (1) made of a second material that is essentially less rigid than the first one and essentially flexible, mainly silicone, a blocking plug (6) for blocking the tube in position in the lacrimal duct and protruding laterally from the tube, characterised in that the length dimension of the tube (1) is smaller than the length dimension of the mandrel (2) and in that the mandrel has a thickness, as measured in a direction perpendicular to the length direction, relative to that of the tube (1) such that it can be inserted inside the tube and withdrawn therefrom.